Sp1074
OPTIMIZING ENDOSCOPIC EVALUATION IN BARRETT'S ESOPHAGUS AND REDUCING PEEC/PEEN IN CLINICAL PRACTICE
Date
May 21, 2024
Presenter
University of Colorado
Tracks
Related Products
LOW INCIDENCE OF RECURRENT NEOPLASTIC BARRETT’S ESOPHAGUS (BE) AFTER SUCCESSFUL ENDOSCOPIC ERADICATION THERAPY (EET): LONG-TERM OUTCOMES FROM A MULTICENTER PROSPECTIVE COHORT STUDY
INTRODUCTION: EET is endorsed by guidelines for treatment of BE-related neoplasia patients. Few studies describe long-term durability outcomes in BE patients who achieve complete eradication of intestinal metaplasia (CE-IM) following EET…
Esophageal, Gastric & Duodenal Disorders (EGD) Section Distinguished Abstract Plenary
SOCIETY: AGA Looking into the crystal ball: novel diagnostic and therapeutic paradigms in foregut disorders
PATIENT CHARACTERISTICS ARE ASSOCIATED WITH RESPONSE TO ERCP FOR SPHINCTER OF ODDI DISORDERS, BUT PHYSICIAN-DEFINED SOD SUBTYPES ARE NOT: THE RESPOND LONGITUDINAL COHORT STUDY
BACKGROUND: Sphincter of Oddi Disorders (SOD) describes a contentious and heterogeneous diagnosis in patients whose abdominal pain, idiopathic acute pancreatitis (AP), or both may derive from a spastic or stenotic sphincter…
VALIDATION OF RISK ASSESSMENT TOOLS FOR THE DETECTION OF BARRETT’S ESOPHAGUS IN PATIENTS WITHOUT CHRONIC REFLUX SYMPTOMS
Esophageal adenocarcinoma (EAC) has had a rising incidence in the US, prompting guidelines for endoscopic screening in those with risk factors for its precursor Barret’s esophagus (BE)…
